The EU: what's best for UK cancer research and patients?

Peter Selby
, Mark Lawler
, Ian Banks
, Patrick Johnston
, Paul Nurse

Research output: Contribution to journal › Comment/debate › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	556-557
Number of pages	2
Journal	Lancet Oncology
Volume	17
Issue number	5
Early online date	27 Apr 2016
DOIs	https://doi.org/10.1016/S1470-2045(16)30063-8
Publication status	Published - May 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1470-2045(16)30063-8Licence: Unspecified

Cite this

@article{27832cd8a50245beacb2394587ec1b03,

title = "The EU: what's best for UK cancer research and patients?",

author = "Peter Selby and Mark Lawler and Ian Banks and Patrick Johnston and Paul Nurse",

year = "2016",

month = may,

doi = "10.1016/S1470-2045(16)30063-8",

language = "English",

volume = "17",

pages = "556--557",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - The EU: what's best for UK cancer research and patients?

AU - Selby, Peter

AU - Lawler, Mark

AU - Banks, Ian

AU - Johnston, Patrick

AU - Nurse, Paul

PY - 2016/5

Y1 - 2016/5

U2 - 10.1016/S1470-2045(16)30063-8

DO - 10.1016/S1470-2045(16)30063-8

M3 - Comment/debate

C2 - 27301027

SN - 1470-2045

VL - 17

SP - 556

EP - 557

JO - Lancet Oncology

JF - Lancet Oncology

IS - 5

ER -